ZIPSCRIPT
Status timeline
- 20 Jun 2024Application filedNew Application Entered
- 14 Jan 2025Assigned to an examining attorneyAssigned To Examiner
- 23 Jan 2025Office action issuedNon-Final Action Written
- 11 Feb 2025Approved for publicationApproved For Pub - Principal Register
- 4 Mar 2025Published for oppositionPublished For Opposition
- 22 Apr 2025Registered on the Principal RegisterRegistered-Principal Register
All 16 USPTO events
| 2025-04-22 | Registered-Principal Register |
| 2025-04-22 | Notice Of Registration Confirmation Emailed |
| 2025-03-04 | Official Gazette Publication Confirmation E-Mailed |
| 2025-03-04 | Published For Opposition |
| 2025-02-26 | Notification Of Notice Of Publication E-Mailed |
| 2025-02-11 | Examiners Amendment -Written |
| 2025-02-11 | Examiners Amendment E-Mailed |
| 2025-02-11 | Notification Of Examiners Amendment E-Mailed |
| 2025-02-11 | Examiner's Amendment Entered |
| 2025-02-11 | Approved For Pub - Principal Register |
| 2025-01-23 | Non-Final Action Written |
| 2025-01-23 | Non-Final Action E-Mailed |
| 2025-01-23 | Notification Of Non-Final Action E-Mailed |
| 2025-01-14 | Assigned To Examiner |
| 2025-01-13 | New Application Office Supplied Data Entered |
| 2024-06-20 | New Application Entered |
Goods & services
Class 1 Chemicals
Chemical, biochemical and biotechnological diagnostic preparations for scientific purposes, namely, buffer solutions for the marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning; chemical test kits for laboratory or research use featuring chemicals for the marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and analysis of biopolymers, in particular nucleic acids, in particular comprising reagents, enzymes and buffer solutions for nucleic acid amplific…
First use anywhere 9 Nov 2017 · First use in commerce 9 Nov 2017
Class 5 Pharmaceuticals & supplements
Diagnostic preparations for medical and veterinary purposes, namely, diagnostics preparations for the marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely, reagents, enzymes and buffer solutions for the marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic …
First use anywhere 9 Nov 2017 · First use in commerce 9 Nov 2017
Source & freshness
Source: USPTO Trademark Applications bulk data. This record was last updated by the USPTO file dated 22 Apr 2025; the index was built on 20 Nov 2026 and covers USPTO data through 31 Aug 2026. Open the official USPTO record (TSDR) → If the two differ, the USPTO record is correct.